ADRENOMYELONEUROPATHY WITHOUT CEREBRAL INVOLVEMENT

Clinical trials for ADRENOMYELONEUROPATHY WITHOUT CEREBRAL INVOLVEMENT explained in plain language.

Never miss a new study

Get alerted when new ADRENOMYELONEUROPATHY WITHOUT CEREBRAL INVOLVEMENT trials appear

Sign up with your email to follow new studies for ADRENOMYELONEUROPATHY WITHOUT CEREBRAL INVOLVEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a common MS drug help people with a rare nerve disease walk better?

Disease control Ongoing

This clinical trial is testing whether dimethyl fumarate, a drug already used for multiple sclerosis, can improve balance and walking in adults with adrenomyeloneuropathy (AMN), a rare nerve disease. Forty participants will take either the drug or a placebo daily for 36 months, w…

Matched conditions: ADRENOMYELONEUROPATHY WITHOUT CEREBRAL INVOLVEMENT

Phase: PHASE2, PHASE3 • Sponsor: Pujol, Aurora, M.D. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

ADRENOMYELONEUROPATHY WITHOUT CEREBRAL INVOLVEMENT

Get alerted when new ADRENOMYELONEUROPATHY WITHOUT CEREBRAL INVOLVEMENT trials appear

Can a common MS drug help people with a rare nerve disease walk better?